@article{10902/30595,
year = {2023},
url = {https://hdl.handle.net/10902/30595},
abstract = {Summary
The OSARIDELPHI study evaluated the level of agreement between specialists in osteoporosis regarding the management of patients with high-risk fractures in Spain. The results provide expert-based recommendations for prevention, diagnosis, and treatment related to fracture risk. Therefore, the study facilitates clinical decision-making for managing this patient's profile.

Purpose
To evaluate the level of agreement between specialists in osteoporosis regarding the management of patients with high-risk fractures in Spain.

Methods
A two-round Delphi study was performed using an online survey. In round 1, panel members rated their level of agreement with assessments on a 9-point Likert scale. Item selection was based on acceptance by ≥ 66.6% of panel experts and the agreement of the scientific committee. In round 2, the same panelists evaluated non-consensus items in round 1.

Results
A total of 80 panelists participated in round 1; of these, 78 completed the round 2 survey. In round 1, 122 items from 4 dimensions (definition of fracture risk: 11 items, prevention and diagnosis: 38 items, choice of treatment: 24 items, and treatment-associated quality of life: 49 items) were evaluated. The consensus was reached for 90 items (73.8%). Panelists agreed that categorizing high risk, very high risk, or imminent risk determines secondary prevention actions (97.5%). Experts agreed that treatment with bone-forming drugs should be considered in case of a very high risk of fracture, and a sequential change to antiresorptive drugs should be made after 1-2 years (97.5%). Panelists also recommended corrective action plans for non-adherent patients to improve adherence (97.5%). A total of 131 items were finally accepted after round 2.

Conclusion
This Delphi study provides expert-based recommendations on clinical decision-making for managing patients with osteoporosis at high risk of fracture.},
organization = {Funding. This study was sponsored by STADA.
Acknowledgements. The authors acknowledge Lola Andreu-Pérez and Alicia Subtil-Rodríguez (both from Evidenze Clinical Research) for project coordination and editorial assistance based on the authors’ input.},
publisher = {Springer},
publisher = {Archives of Osteoporosis, 2023, 18, 110},
title = {A Delphi consensus on the management of spanish patients with osteoporosis at high risk of fracture: OSARIDELPHI study},
author = {Arboleya, Luis and Cancio-Trujillo, José Manuel and Chaves, Celia and Duaso-Magaña, Enric and Mesa-Ramos, Manuel and Olmos Martínez, José Manuel},
}